View:
Download DOC
Download PDF
Download XLS
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
MCGINLEY MARK D
(Last) (First) (Middle)
5960 HEISLEY ROAD
(Street)
MENTOR OH 44060
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STERIS CORP [ STE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Sr. VP, Gen Counsel, and Sec.
3. Date of Earliest Transaction (Month/Day/Year)
05/31/2013
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares, No Par Value 05/31/2013 F 263(1) D $45.34 17,629(2) D
Common Shares, No Par Value 7,022 I See Footnote Below.(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. 263 shares were withheld from the 800 restricted shares that vested on May 31, 2013. These 263 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 800 shares were awarded to Mr. McGinley on May 31, 2011 as part of an award of 3,200 restricted shares. These vested shares were valued at the NYSE closing market price on May 31, 2013.
2. 5,800 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 4,200 on May 20, 2014, 800 on June 2, 2014 and 800 on June 1, 2015.
3. Represents 7,168.007 units of the STERIS Corporation 401(k) Plan STERIS Stock Fund which equals 7,022 Common share equivalents as of May 31, 2013.
/s/ Dennis P. Patton, Authorized Representative under Power of Attorney 06/03/2013
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
rrd343487_388341.html 
Securities and Exchange Commission
Washington, D.C. 20549
RE: STERIS Corporation
Commission File No. 0-20165
1933 Act and 1934 Act Filings

Authorized Representatives

Gentlemen:

      The above Company is the issuer of securities registered under Section 12 of the
Securities Exchange Act of 1934. The person signing below confirms, as of the date
appearing opposite his signature, that each of the "Authorized Representatives" named
below is authorized on his behalf to sign such statements (on Form 3, Form 4, Form 5,
Form 144, Schedule 13G, or otherwise) with respect to securities of the Company (the
"Securities"), and to submit to the Securities and Exchange Commission such filings
(including reports, notices, and other statements) with respect to the Securities, as are
required by the Securities Act of 1933 or the Securities Exchange Act of 1934
(collectively, the "Acts"). The person so signing also confirms the authority of each of
the Authorized Representatives to do and perform, on his behalf, any and all acts and
things with respect to the Securities requisite or necessary to assure compliance by the
signing person with the filing requirements of the Acts. The authority confirmed herein
shall remain in effect as to the person signing below until such time as the Commission
shall receive from that person a written communication terminating or modifying the
authority.

Authorized Representatives
 Mark D. McGinley
 Michael J.Tokich
 Ronald E. Snyder
 Dennis P. Patton
 J. Adam Zangerle

Dated:  January 14, 2008				By:  /s/ Mark D. McGinley